MLYS

MINERALYS THERAPEUTICS INC

MLYS·603170101·US·Common Stock·Healthcare - Biotechnology-Activist

MLYS (MINERALYS THERAPEUTICS INC) is held by 114 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($208.4M), FMR LLC ($131.7M), BlackRock, Inc. ($121.4M). Net institutional sentiment: Mixed.

114
Holders
(7 Elite)
$1.4B
Total Value
62% (116)
Consensus
72 buying - 44 selling
13F: Insider & Congress:
MLYSSmart Money Verdict
View all
Held by 114 funds
7 elite
Who's Trading
InsiderRMRodman David MalcomSell $169KJul 15, 2026
InsiderCJCongleton JonSell $291KJul 13, 2026
InsiderRMRodman David MalcomSell $388KJul 13, 2026
InsiderRMRodman David MalcomSell $66KJul 9, 2026
InsiderCJCongleton JonSell $1.5MJun 30, 2026
InsiderCJCongleton JonSell $456KJun 30, 2026
InsiderWEWarren EricSell $2.7MJun 26, 2026
InsiderRMRodman David MalcomSell $13KApr 17, 2026
ActivistCPCatalys Pacific Fund, LP10.1%Feb 13, 2026
ActivistFMR LLCFMR LLC6.3%Feb 5, 2026
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
7.7M(+5.0%)$208.4M2.2%+48.36%
55
Decreased
4.9M(-3.9%)$131.7M0.0%-19.97%
0
Increased
4.5M(+3.6%)$121.4M0.0%+40.57%
31
Increased
3.4M(+328.3%)$91M0.0%-5.79%
48
Decreased
2.9M(-7.8%)$79.5M0.0%+8.87%
0
New
2.5M$66.5M0.0%-0.46%
41
Increased
1.9M(+58.3%)$51.8M0.1%-19.73%
42
Decreased
1.8M(-0.2%)$48.3M0.0%+125.24%
0
Increased
1.5M(+7.1%)$40.7M0.1%-24.83%
37
Increased
1.3M(+1.4%)$36.4M0.0%-19.11%
29
Increased
975,961(+5.8%)$35.4M0.0%-25.09%
31
Increased
1.3M(+3.5%)$35.3M0.0%+44.55%
30
Increased
1.3M(+0.6%)$34.3M0.0%-1.56%
29
Increased
1.1M(+11.4%)$29.8M0.0%-9.19%
32
Increased
1M(+21.3%)$28M0.0%+66.38%
34
Increased
914,728(+84.2%)$24.8M0.0%+1.33%
44
Decreased
887,192(-22.9%)$24M0.0%+12.87%
0
Decreased
884,107(-2.6%)$24M0.0%+92.38%
0
Increased
849,184(+32.8%)$23M0.0%+1.84%
37
Increased
801,904(+18.2%)$21.7M0.1%+48.25%
40

Showing 1-20 of 123

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used